Description: This webcast will detail interpretable machine learning techniques for participants to gain an intuition and understanding about the use of these techniques. We will discuss how to apply them, how to understand them, and how to avoid potential pitfalls.

Description: From a session at a meeting of the Society of Actuaries held in Las Vegas, NV May 22-24, 2000 This session features a presentation by a nontraditional actuary who offers a mathematical look at gambling. The speaker discusses his experience with actuarial consulting pertaining to the study of old and new forms of casino gambling.

Description: Regression to the mean (RTTM) is inflating your health care intervention evaluations if you are not carefully managing it's omnipresent and significant impact RTTM is the statistical phenomenon which arises when comparing sequential data points when an initial observation is extreme or an outlier, and states that with no other intervention, future observations will be closer to the average. Members who had high costs last year will, on average, have lower costs this year, even in the absence of any intervention or clinical program, simply by 'regressing' to the mean. This means that if your clinical programs are simply targeting members who had adverse medical experience last year, you’re targeting the wrong people. And if your savings methodologies are simply last year’s costs minus this year’s costs, the savings are inflated. By attending this session, you will be able to identify situations where RTTM will be a significant factor, how to eliminate it's impact when performing retrospective evaluations, how to identify prospects for clinical intervention with RTTM in mind, and more.

Description: This paper provides actuaries with background and scientific knowledge to understand global climate change and climate model projections for the 21st century.

Description: In this article the author presents a general solution to the problem of finding the effective annual interest rate commonly arising in finance for an installment loan.

Description: Data science, predictive analytics and AI are certainly the buzzwords these days. They are heavily used and developed in underwriting and marketing but for most actuaries, they might/may as well be science fiction. The presenters will demonstrate how a normal actuary can utilize data science techniques in their daily job function without forming an official data science team within a company. It can be done in a gradual fashion so that normal business is not disrupted and improvements are made over time. The usage of data science techniques will include demonstrations of the following areas: - Regression analysis - Economic scenario generator - Experience study - Data quality checks - Inforce compression for explicit hedging

Description: The cloud inspires awe and fear in equal parts these days. There is a need to learn more, but there’s much information to learn and it may be difficult to know what to learn next. In this session, we’ll carve off a small corner of the cloud and make it your own. Setting up a Data Science Virtual Machine on Digital Ocean will be demonstrated. It’s the fastest way to get a data science development environment setup for your own use. Many of the topics and ideas covered will apply to almost all other cloud offerings. What use cases Digital Ocean is good for, and what use cases you should look elsewhere for, will also be discussed.

Description: Actuaries historically modeled new launches in pharmaceuticals by anticipating the expected change to the market basket. This became more complicated with the recent launches of gene and cell therapies as they address rare diseases. Rare conditions have low total member volume to study and some do not currently have a diagnosis code to identify them within claims data. Addressing this modeling challenge has been growing more important in the recent years with the number of therapies launching. What has the health care industry, and more specifically health care, done to enhance modeling and how should this be altered for the future? Additionally, historic modeling has sometimes incorporated a level of direct medical treatment cost offsets where studies have shown lower treatment costs are achievable. Can gene and cell financial modeling include cost offsets as well? And if so, what are suggested precautions or limitations to this effort?

Description: This article introduces the reader to probabilistic methods used to model interactions in the financial market place. Three topics are specifically discussed, two concern modeling methods and the other concerns data analysis methods.

Description: Discussion of a newly released LTC experience study, including description of data and its increased scope compared to the prior report, reporting specifications, and findings.